EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl
Cannabis Law Report
JULY 23, 2019
(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. LGC’s investment will build on this growth mom.
Let's personalize your content